Skip to content
Medical Health Aged Care

Foundation for GP research will build healthier communities

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) yesterday relaunched its Australian General Practice Research Foundation with a new focus on innovation and impact to improve patient care and health outcomes. 

The Foundation’s patron Professor Michael Kidd AO, a globally recognised leader in general practice and primary care, will support the Foundation’s mission to champion excellence and innovation in general practice research. 

Professor Kidd AO said: “General practice impacts the lives of millions of Australians every year, yet general practice research has often been underfunded and undervalued. 

“This Foundation is our chance to change that and ensure that all GPs have access to the evidence-based tools and resources they need to deliver the best possible care to their patients.  

“I feel privileged to have this opportunity to champion the transformative power of general practice research and its role in helping to create healthier communities across our nation." 

RACGP President Dr Michael Wright said: “The RACGP’s dedication to advancing general practice and its tireless efforts to support GPs across the country have laid the groundwork for this vital initiative. 

“The RACGP has been at the forefront of promoting general practice research for over 60 years and the relaunch of our Foundation signifies our renewed commitment to drive innovation. 

“General practice is the core of Australia’s healthcare system, and we need to keep that core strong by using research to innovate and adapt to our country’s complex and evolving healthcare needs.  

“Major and large grants are open now till 4 April with the general grants round opening 12 May.   

“The RACGP is also calling for all political parties to commit to funding a national practice-based research network in Australia and research into multidisciplinary practice teams – which will improve access to care and reduce costs for patients. Practice-based research networks have had great success overseas, including in Canada, where they produce evidence to improve care for prominent health issues including chronic illness, ageing, addiction, and allergies.    

“These crucial research initiatives, alongside the Foundation, will build a stronger academic GP workforce and research base, improving access to care, reducing hospital admissions and reducing costs for patients.” 

Foundation Committee Chair Sarah Lance sees the Foundation as an important opportunity to deliver meaningful outcomes and make a tangible difference in Australian healthcare. 

“General practice is the backbone of our health system, with 9 in 10 Australians visiting their GP each year,” she said. 

““Yet, despite this critical role, general practice receives less than 2% of our national medical research funding.  

“The Australian General Practice Research Foundation aims to bridge this gap, providing the necessary resources for research that supports GPs in delivering the best possible care.” 

“The Foundation will support GPs across Australia to drive innovation and develop real-world solutions. We are calling on GPs with big ideas to tackle pressing health challenges, improve patient care and strengthen the future of general practice. 

“Through funding and fostering research, we can unlock innovations that will improve care on a scale that benefits every corner of the country.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992[email protected]

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 26/04/2025
  • 08:04
Monash University

The power of pets in reducing loneliness and social isolation for at-risk groups

A new pilot program funded by the National Centre for Healthy Ageing (NCHA), a partnership between Monash University and Peninsula Health, is the first to use a shared interest in pets to help build connections between young and older adults to reduce loneliness and social isolation. Social isolation and loneliness stem from a reduced sense of belonging, due to a lack of social connections, and can lead to detrimental effects on physical health and cognitive decline. These experiences have been exacerbated due to the COVID-19 pandemic. Two of the most impacted groups in relation to social isolation and loneliness are…

  • Medical Health Aged Care
  • 25/04/2025
  • 18:11
Elixir Medical Corporation

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea.Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an external energy source.MILPITAS, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the first clinical use of its LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in the Asia Pacific region, marking a significant milestone in the device's global introduction. The procedures were successfully performed…

  • Medical Health Aged Care
  • 25/04/2025
  • 09:59
Monash University

Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity: study

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found. Metformin, which is commonly prescribed to treat type 2 diabetes, reduced knee arthritis pain over six months in a clinical trial published in JAMA. The randomised clinical trial looked at whether metformin, compared to a placebo, reduced knee pain in patients withsymptomatic knee osteoarthritis (knee OA) andoverweight or obesity. The research was performed entirely as a community-based study using telehealth. Some of the 107 participants with pain from knee osteoarthritis (73…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.